Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
b-cell chronic lymphocytic leukemia | — | D015451 | C91.1 |
Expiration | Code | ||
---|---|---|---|
alemtuzumab, Campath , Genzyme Corporation | |||
2108-05-07 | Orphan excl. | ||
alemtuzumab, Lemtrada, Genzyme Corporation | |||
2108-05-07 | Orphan excl. |
Code | Description |
---|---|
J0202 | Injection, alemtuzumab, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 2 | 2 | 6 | 6 | 5 | 20 |
Sclerosis | D012598 | — | — | 2 | 2 | 6 | 5 | 4 | 18 |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | 1 | 4 | 4 | 1 | 10 |
Nerve degeneration | D009410 | — | — | — | — | — | 1 | — | 1 |
Chronic inflammatory demyelinating polyradiculoneuropathy | D020277 | EFO_1000868 | G61.81 | — | — | — | 1 | — | 1 |
Polyradiculoneuropathy | D011129 | EFO_1001116 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 4 | 7 | 2 | — | 3 | 14 |
Lymphoid leukemia | D007945 | — | C91 | 3 | 5 | 2 | — | 2 | 11 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | 4 | 2 | — | 2 | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 4 | 4 | — | — | — | 5 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | 2 | — | — | — | 3 |
Myelodysplastic syndromes | D009190 | — | D46 | 1 | 1 | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Myeloid leukemia | D007951 | — | C92 | 1 | 1 | — | — | — | 1 |
Preleukemia | D011289 | — | — | 1 | 1 | — | — | — | 1 |
Prolymphocytic leukemia t-cell | D015461 | — | C91.6 | — | 1 | — | — | — | 1 |
Prolymphocytic leukemia | D015463 | — | — | — | 1 | — | — | — | 1 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 1 | 1 | — | — | — | 1 |
T-cell lymphoma | D016399 | — | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 1 | — | — | — | — | 1 |
B-cell lymphoma | D016393 | — | — | 1 | — | — | — | — | 1 |
Chronic progressive multiple sclerosis | D020528 | EFO_0003840 | — | 1 | — | — | — | — | 1 |
Graft vs host disease | D006086 | — | D89.81 | 1 | — | — | — | — | 1 |
Hematologic neoplasms | D019337 | — | — | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
B-cell leukemia | D015448 | — | — | — | — | — | — | 1 | 1 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Drug common name | Alemtuzumab |
INN | alemtuzumab |
Description | Immunoglobulin G 1 (human-rat monodonal CAMPATH-1H 71-chain anti-human antigen CD52), disulfide with human-rat monoclonal CAMPATH-1H light chain, dimer |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | >1CE1:H|PROTEIN (CAMPATH-1H:HEAVY CHAIN)
QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQ
FSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTV
SWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVE
>1CE1:L|PROTEIN (CAMPATH-1H:LIGHT CHAIN)
DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQP
EDIATYYCLQHISRPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR |
PDB | 1BEY, 1BFO, 1CE1, 6OBD |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201587 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00087 |
UNII ID | 3A189DH42V (ChemIDplus, GSRS) |